Holliday junction recognition protein as a prognostic biomarker and therapeutic target for oral cancer.

Tsevegjav, Bayarbat; Takano, Atsushi; Zhu, Ming; Yoshitake, Yoshihiro; Shinohara, Masanori; Daigo, Yataro

Tsevegjav, Bayarbat; Takano, Atsushi; Zhu, Ming; Yoshitake, Yoshihiro; Shinohara, Masanori; Daigo, Yataro.

Afiliação

Tsevegjav B; Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Shiga 5202192, Japan.
Takano A; Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Shiga 5202192, Japan.
Zhu M; Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Shiga 5202192, Japan.
Yoshitake Y; Department of Oral and Maxillofacial Surgery, Kumamoto University, Kumamoto 8608555, Japan.
Shinohara M; Department of Oral and Maxillofacial Surgery, Kumamoto University, Kumamoto 8608555, Japan.
Daigo Y; Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Shiga 5202192, Japan.

Int J Oncol ; 60(3)2022 Mar.

Article em En | MEDLINE | ID: mdl-35103286

Assuntos

Linhagem Celular Tumoral/metabolismo; Proteínas de Ligação a DNA/análise; Neoplasias Bucais/genética; Biomarcadores Tumorais/análise; Biomarcadores Tumorais/sangue; Proteínas de Ligação a DNA/sangue; Humanos; Neoplasias Bucais/sangue; Prognóstico

Palavras-chave

Holliday junction recognition protein; biomarker; oncoantigen; oral cancer; therapeutic target

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Bucais / Linhagem Celular Tumoral / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google